CA2128535A1 - Methode de retardement du sida provoque par le vih par l'administration de composes azaperane substitues - Google Patents

Methode de retardement du sida provoque par le vih par l'administration de composes azaperane substitues

Info

Publication number
CA2128535A1
CA2128535A1 CA002128535A CA2128535A CA2128535A1 CA 2128535 A1 CA2128535 A1 CA 2128535A1 CA 002128535 A CA002128535 A CA 002128535A CA 2128535 A CA2128535 A CA 2128535A CA 2128535 A1 CA2128535 A1 CA 2128535A1
Authority
CA
Canada
Prior art keywords
compound
carbon atoms
hydrate
pharmaceutically acceptable
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002128535A
Other languages
English (en)
Inventor
Alison Mary Badger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2128535A1 publication Critical patent/CA2128535A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002128535A 1992-01-28 1993-01-27 Methode de retardement du sida provoque par le vih par l'administration de composes azaperane substitues Abandoned CA2128535A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929201803A GB9201803D0 (en) 1992-01-28 1992-01-28 Methods
GB9201803.5 1992-01-28

Publications (1)

Publication Number Publication Date
CA2128535A1 true CA2128535A1 (fr) 1993-08-05

Family

ID=10709398

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002128535A Abandoned CA2128535A1 (fr) 1992-01-28 1993-01-27 Methode de retardement du sida provoque par le vih par l'administration de composes azaperane substitues

Country Status (7)

Country Link
EP (1) EP0624089A4 (fr)
JP (1) JPH07503252A (fr)
KR (1) KR950700068A (fr)
AU (1) AU666175B2 (fr)
CA (1) CA2128535A1 (fr)
GB (1) GB9201803D0 (fr)
WO (1) WO1993014760A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
US7273859B2 (en) * 2004-05-12 2007-09-25 Bristol-Myers Squibb Company HIV integrase inhibitors: cyclic pyrimidinone compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US181704A (en) * 1876-08-29 Improvement in flour-dressing machines
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
WO1992004899A1 (fr) * 1990-09-24 1992-04-02 Smithkline Beecham Corporation Methodes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors

Also Published As

Publication number Publication date
WO1993014760A3 (fr) 1993-09-02
EP0624089A1 (fr) 1994-11-17
JPH07503252A (ja) 1995-04-06
WO1993014760A2 (fr) 1993-08-05
AU666175B2 (en) 1996-02-01
AU3595193A (en) 1993-09-01
EP0624089A4 (en) 1994-12-14
GB9201803D0 (en) 1992-03-11
KR950700068A (ko) 1995-01-16

Similar Documents

Publication Publication Date Title
JP2904827B2 (ja) 不安および不安抑うつ障害の処置に有用な医薬組成物の調製へのトリフルオロメチルフェニルテトラヒドロピリジンの使用
CA2128535A1 (fr) Methode de retardement du sida provoque par le vih par l'administration de composes azaperane substitues
HUT53285A (en) Process for producing pharmaceutical compositions comprising ace inhibitor and suitable for treating toxicomania
US5482959A (en) Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds
AU7370894A (en) Method of inhibiting the production of human immunodeficiency viruses with substituted azaspiranes
AU7370994A (en) Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes
WO1995003049A1 (fr) Procedes de traitement du vih au moyen d'azaspiranes
US5786376A (en) Methods of treating opportunistic infections with azaspiranes
AU684384B2 (en) Method of treating opportunistic infections with azaspiranes
AU710542B2 (en) Use of substituted azaspirane in the treatment of asthma
WO1993015735A1 (fr) Procede (non descriptif) de retardement du sida chez des sujets contamines par le vih par administration de composes d'azaspirane substitue
JPH04108731A (ja) 抗エイズウイルス剤
WO1995003048A1 (fr) Azaspiranes anti-hiv
JPH09500647A (ja) 置換アザスピランによるヒト免疫不全ウイルス産生の阻害法
WO1995003046A1 (fr) Procede d'inhibition de la production de vih
JPS6231682B2 (fr)
WO1995003047A1 (fr) Traitements s'exercant contre le virus de l'immunodeficience chez l'homme

Legal Events

Date Code Title Description
FZDE Dead